Clinical Trial Update: A Study of HS-20093 vs Active Surveillance in Limited-Stage Small Cell Lung Cancer [Phase 3]

View source ↗

Summary

This document describes a Phase 3 clinical trial comparing HS-20093 to active surveillance in patients with limited-stage small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Limited-stage Small Cell Lung Cancer
• Small Cell Lung Cancer

Drugs mentioned

• HS-20093

Snippet

Sponsor: Hansoh BioMedical R&D Company | Conditions: Limited-stage Small-cell Lung Cancer | Phase 3 | Status: NOT_YET_RECRUITING